A Novel Signature of Serum Interleukin 3 in Ankylosing Spondylitis

Read full text Summarise with VIRAT
Authors: Baneen Mueen Abd Ali, Inas Khalifa Sharquie, Faiq I. Gorial
Cited by: 0
References: 37

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

spondylitis (AS), which is regulated by numerous cytokines. Interleukin-3 (IL-3) involvement as a biomarker for AS has remained unexplored. Therefore, this study aims to assess serum IL-3 levels to improve the accuracy of AS diagnostics and enhance targeted therapies while exploring the role of human leukocyte antigen (HLA-B27) in influencing IL-3. The study examined the IL-3 serum levels of 88 patients with AS and 44 healthy controls recruited from the Baghdad Teaching Hospital. Patients with AS disease were further divided into two subcategories according to AS status: inactive (n = 44) and active (n = 44). Serum IL-3 titers were quantified using enzyme-linked immunosorbent assay (ELISA). Clinical parameters like complete medical histories, body mass index, sex, age, and disease duration were also recorded. Additionally, laboratory disease parameters, such as HLA-B27, C-reactive protein, and rheumatoid factor, were analyzed. IL-3 levels were higher in the AS patients (456.63 ± 237.118 pg/ml) than in the healthy controls (178.21 ± 16.015 pg/ml, p < 0.01). The mean IL-3 levels were highest in patients with active AS (663.27 ± 156.293 pg/ml) and became incrementally lower with reduced disease severity, inactive, 250 ± 44.148 pg/ml. Serum IL-3 exhibited strong diagnostic for AS, demonstrating a cut-off value of ≥ 193 pg/ml as well as an area under the curve score of 0.997. Sensitivity, accuracy, in addition to specificity were 98.9%, 91.67%, and 77.3%, respectively. In conclusion, serum IL-3 levels were significantly elevated in AS patients and correlated to the disease's activity. This suggests that IL-3 could be valuable in predicting disease severity and monitoring AS progression.

Fields of Study & Subjects

Spondyloarthritis Studies and Treatments Ocular Diseases and Behçet’s Syndrome Sarcoidosis and Beryllium Toxicity Research

Publication details

Journal / source
Iraqi Journal of Science
Pages
1556–1569
Publication date
30 March 2026
Language
EN